A bridge, not a destination: clarifying the role of polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma

Ho Young Yhim

doi:10.3904/kjim.2025.054

A bridge, not a destination: clarifying the role of polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma

Ho Young Yhim^*

^*Corresponding author for this work

Department of Medicine

Research output: Contribution to journal › Editorial

Original language	English
Pages (from-to)	183-185
Number of pages	3
Journal	Korean Journal of Internal Medicine
Volume	41
Issue number	2
DOIs	https://doi.org/10.3904/kjim.2025.054
State	Published - 2026.03

Access to Document

10.3904/kjim.2025.054

Cite this

@article{dbcd0b760a9c4e0695c1760edd8267a6,

title = "A bridge, not a destination: clarifying the role of polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma",

author = "Yhim, \{Ho Young\}",

year = "2026",

month = mar,

doi = "10.3904/kjim.2025.054",

language = "English",

volume = "41",

pages = "183--185",

journal = "Korean Journal of Internal Medicine",

issn = "1226-3303",

number = "2",

}

TY - JOUR

T1 - A bridge, not a destination

T2 - clarifying the role of polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma

AU - Yhim, Ho Young

PY - 2026/3

Y1 - 2026/3

UR - https://www.scopus.com/pages/publications/105032788085

U2 - 10.3904/kjim.2025.054

DO - 10.3904/kjim.2025.054

M3 - Editorial

C2 - 41850214

AN - SCOPUS:105032788085

SN - 1226-3303

VL - 41

SP - 183

EP - 185

JO - Korean Journal of Internal Medicine

JF - Korean Journal of Internal Medicine

IS - 2

ER -

A bridge, not a destination: clarifying the role of polatuzumab vedotin plus bendamustine and rituximab in relapsed/refractory diffuse large B-cell lymphoma

Access to Document

Other files and links

Cite this